Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients

Authors: Azzahhafi, Jaouad ^{a, ∗, ∗}, van den Broek, Wout W.A. ^a, Chan Pin Yin, Dean R.P.P. ^a, van der Sangen, Niels M.R. ^b, Sivanesan, Shabiga ^b, Bofarid, Salahodin ^a, Peper, Joyce ^a, Claassens, Daniel M.F. ^c, Janssen, Paul W.A. ^d, Harmsze, Ankie M. ^e, Walhout, Ronald J. ^f, Tjon Joe Gin, Melvyn ^g, Nicastia, Deborah M. ^h, Langerveld, Jorina ⁱ, Vlachojannis, Georgios J. ^j, van Bommel, Rutger J. ^k, Appelman, Yolande ^l, van Schaik, Ron H.N. ^m, Henriques, José P.S. ^b, Kikkert, Wouter J. ^{b, k}, ten Berg, Jurriën M. ^{a, n}

Source: In JACC: Cardiovascular Interventions 9 September 2024 17(17):1996-2007

The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study

Authors: bij de Weg, Jeske M., Landman, Anadeijda J.E.M.C., de Vries, Johanna I.P., Thijs, Abel, Harmsze, Ankie M., Oudijk, Martijn A., de Boer, Marjon A.

Source: In European Journal of Obstetrics & Gynecology and Reproductive Biology November 2022 278:67-71

Increased frequency of CYP2C19 loss‐of‐function alleles in clopidogrel‐treated patients with recurrent cerebral ischemia

Authors: Minderhoud, Crista, Otten, Leila S., Hilkens, Pieter H. E., Broek, Marcel P. H., Harmsze, Ankie M.

Source: British journal of clinical pharmacology. 88(7):3335-3340

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100153621710.0x000001&indx=1&recIds=ETOCvdc_100153621710.0x000001

Resistance of aspirin during and after pregnancy: A longitudinal cohort study

Authors: bij de Weg, Jeske M., Abheiden, Carolien N.H., Fuijkschot, Wessel W., Harmsze, Ankie M., de Boer, Marjon A., Thijs, Abel, de Vries, Johanna I.P.

Source: In Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health January 2020 19:25-30

Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions

Authors: Zhang, Zhu Xian, Garde, Ewoudt M. W., Söhne, Maaike, Harmsze, Ankie M., Broek, Marcel P. H.

Source: British journal of clinical pharmacology. 86(8):1567-1574

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107398224.0x000001&indx=1&recIds=ETOCvdc_100107398224.0x000001

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.

Authors: Drent, Marjolein, Wijnen, Petal A., Jessurun, Naomi T., Harmsze, Ankie M., Bekers, Otto, Bast, Aalt

Source: Drug Safety; Apr2024, Vol. 47 Issue 4, p355-363, 9p

Subject Terms: INTERSTITIAL lung diseases, LUNGS, DRUG side effects, IDIOPATHIC pulmonary fibrosis, PULMONARY fibrosis, CYTOCHROME P-450, CYTOCHROME P-450 CYP2D6

Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy

Authors: Abheiden, Carolien N.H., Fuijkschot, Wessel W., Arduç, Arda, van Diemen, Jeske J.K., Harmsze, Ankie M., de Boer, Marjon A., Thijs, Abel, de Vries, Johanna I.P.

Source: In European Journal of Obstetrics and Gynecology March 2017 210:139-143

Subdivision of aspirin tablets? Use your hands: a study on aspirin tablet subdivision using four different methods

Authors: van Reuler, A. V., van Diemen, J. J., Harmsze, A. M., Fuijkschot, W. W., Thijs, A.

Source: JOURNAL OF PHARMACY PRACTICE AND RESEARCH. 48(1):44-48

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN387809439&indx=1&recIds=ETOCRN387809439

Authors' response to Letter to the Editor on The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study

Authors: bij de Weg, Jeske M., Landman, Anadeijda J.E.M.C., de Vries, Johanna I.P., Thijs, Abel, Harmsze, Ankie M., Oudijk, Martijn A., de Boer, Marjon A.

Source: European journal of obstetrics, gynecology, and reproductive biology. 282:172-172

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184645586.0x000001&indx=1&recIds=ETOCvdc_100184645586.0x000001

Review of global regulations concerning biowaivers for immediate release solid oral dosage forms
Advances in understanding oral absorption and delivery of problem compounds: selected papers from the 3rd World Conference on Drug Absorption, Transport and Delivery

Authors: Gupta, E., Barends, D. M., Yamashita, E., Lentz, K. A., Harmsze, A. M., Shah, V. P., Dressman, J. B., Lipper, R. A.

Source: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 29(3-4):315-324

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN061885016&indx=1&recIds=ETOCCN061885016

CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel

Authors: Peters, Bas JM, Harmsze, Ankie M, ten Berg, Jurriën M, Maitland-van der Zee, Anke-Hilse, Tjoeng, Mathieu M, de Boer, Anthonius, Deneer, Vera HM

Source: Pharmacogenomics. 12(2):141-144

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121256585.0x000001&indx=1&recIds=ETOCvdc_100121256585.0x000001

Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

Authors: HARMSZE, A. M., VAN WERKUM, J. W., SOUVEREIN, P. C., BREET, N. J., BOUMAN, H. J., HACKENG, C. M., RUVEN, H. J., TEN BERG, J. M., KLUNGEL, O. H., DE BOER, A.

Source: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 9(10):1892-1901

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN299159496&indx=1&recIds=ETOCRN299159496

Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients

Authors: Harmsze, A. M., Van Werkum, J. W., Moral, F., Ten Berg, J. n., Hackeng, C. M., Klungel, O. H., De Boer, A., Deneer, V. H.

Source: PLATELETS -EDINBURGH-. 22(2):98-102

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN292411799&indx=1&recIds=ETOCRN292411799

CYP2C192 and CYP2C93 alleles are associated with stent thrombosis: a case-control study

Authors: Harmsze, A. M., van Werkum, J. W., ten Berg, J. M., Zwart, B., Bouman, H. J., Breet, N. J., van t Hof, A. W., Ruven, H. J., Hackeng, C. M., Klungel, O. H.

Source: EUROPEAN HEART JOURNAL. 31(24):3046-3053

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN299912046&indx=1&recIds=ETOCRN299912046

The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence

Authors: van Werkum, J. W., Harmsze, A. M., Elsenberg, E. H., Bouman, H. J., ten Berg, J. M., Hackeng, C. M.

Source: PLATELETS -EDINBURGH-. 19(7):479-488

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN239602792&indx=1&recIds=ETOCRN239602792

Langdurig verminderd effect van cumarinederivaten na gebruik van rifampicine

Authors: Harmsze, A. M., Deneer, V. H. M., Wiltink, E. H.

Source: NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE. 151(35):1945-1949

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN214874414&indx=1&recIds=ETOCRN214874414

The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry.

Authors: Azzahhafi, Jaouad, Broek, Wout W. A. van den, Chan Pin Yin, Dean R. P. P., Harmsze, Ankie M., van Schaik, Ron H. N., ten Berg, Jurriën M.

Source: Journal of Cardiovascular Pharmacology & Therapeutics; Jan-Dec2023, Vol. 28, p1-9, 9p

Subject Terms: ACUTE coronary syndrome, PRASUGREL, CYTOCHROME P-450 CYP2C19, PHYSICIAN adherence, TURNAROUND time, COST control

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study.

Authors: van Uden, Renate C. A. E., van den Broek, Marcel P. H., Houtenbos, Ilse, Jaspers, Tessa C. C., Harmsze, Ankie M., Kingma, Hylke J., Odekerken, Diego A. M., Meijer, Karina, van den Bemt, Patricia M. L. A., Becker, Matthijs L.

Source: European Journal of Clinical Pharmacology; Dec2021, Vol. 77 Issue 12, p1919-1926, 8p, 1 Illustration, 4 Charts

Subject Terms: FIBRINOLYTIC agents, OCCUPATIONAL roles, EXPERIMENTAL design, ENOXAPARIN, ACADEMIC medical centers, ANTICOAGULANTS, MEDICAL protocols, HOSPITAL care, DESCRIPTIVE statistics, PLATELET aggregation inhibitors, PATIENT compliance, LONGITUDINAL method

Geographic Terms: NETHERLANDS

Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity.

Authors: Jessurun, Naomi T., Drent, Marjolein, Wijnen, Petal A., Harmsze, Ankie M., van Puijenbroek, Eugène P., Bekers, Otto, Bast, Aalt

Source: Drug Safety; Nov2021, Vol. 44 Issue 11, p1179-1191, 13p

Subject Terms: SIMVASTATIN, PULMONARY toxicology, PHARMACOGENOMICS, BIOCHEMICAL genetics, GENETIC engineering, PROTEINS, RESEARCH, ANTILIPEMIC agents, RESEARCH methodology, EVALUATION research, COMPARATIVE studies, DRUG interactions, OXIDOREDUCTASES, HEMOPROTEINS

Patient's Estimation of Efficacy of Various Hyperhidrosis Treatments in a Dermatological Clinic.

Authors: Amini, Mohammad¹, Harmsze, Ankie M.², Tupker, Ron A.¹ r.tupker@antonius.net

Source: Acta Dermato-Venereologica. 2008, Vol. 88 Issue 4, p356-362. 7p.

Subject Terms: *HYPERHIDROSIS treatment, *QUALITY of life, *DERMATOLOGY, *PATIENTS, *SKIN diseases